ARTICLE

FindCenter AddIcon

Ketamine for Depression Still Too Expensive for Widespread Use

By Technology Networks — 2020

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use. The study compared the costs and benefits of esketamine, an antidepressant approved by the U.S. Food and Drug Administration (FDA) last year for use in treatment-resistant major depressive disorder.

Read on www.technologynetworks.com

FindCenter Post-Image

An Introduction to Rest

Some people harbor the illusion that rest is a luxury they do not have time for, but the reality is that rest is a necessity.

FindCenter AddIcon
FindCenter Post-Image

Social Isolation’s High Physical and Psychological Toll

Studies of polar researchers, astronauts, and others in isolation shed light on possible effects of social distancing, including increased forgetfulness, depression and heart attacks.

FindCenter AddIcon

EXPLORE TOPIC

Clinical Depression